Aptah Bio Alternatives & Competitors
12 companies similar to Aptah Bio — The next generation of RNA therapeutics for age-related diseases
Companies similar to Aptah Bio
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Eisai US
Breaking through in the therapeutic areas of oncology and neurology. View our community gu...
Qualisure Diagnostics Inc.
Deploying AI-enabled molecular diagnostics globally through decentralized testing and cent...
Sapience Therapeutics, Inc.
Changing the Tide to Achieve the Unachievable
Rival Readout
Competing with Aptah Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmunAbs Inc.
ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope f...
LAVA Therapeutics N.V.
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fi...
Convert Pharmaceuticals
Overcoming cancer treatment resistance with hypoxia-activated prodrugs.
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
Adela, Inc.
Advancing the field of epigenomics to transform how cancer is detected and monitored.
Sarcura
Powering New Possibles in Cell Therapy Manufacturing
FREZENT Biological
Preventing cancer recurrence
TenSixty Biosciences
We're on a mission to create transformative drugs that will save lives and redefine oncolo...
About Aptah Bio
Aptah Bio, founded in 2019 and headquartered in the United States, is making strides in the biotechnology and pharmaceutical sectors. The company's slogan, "The next generation of RNA therapeutics for age-related diseases," encapsulates its mission to eradicate ailments associated with aging. With a strategic aim to tr...
Developing RNA-based therapies, Restoring transcription fidelity, Reducing tumor heterogeneity, Enhancing existing cancer therapies
Oncologists, Cancer treatment centers, Pharmaceutical companies, Biotechnology investors, Patients with aggressive cancer types
RNA Therapeutics, Age-related Diseases, Neurodegenerative Diseases, Pharmaceuticals, Biopharmaceuticals, Genome-wide Transcription Modulation, Patent Attorneys, Biotech Startup, Economic Impact, Global Health, Aging Population, Epidemiology, Investment Potential
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Aptah Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Aptah Bio on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.